At Tiger BioSciences, we are the new leaders in regenerative medicine. We believe that cell and tissue technologies can drive the future of regenerative medicine. Innovation around compliant tissue engineering, tissue processing and devices that support these technologies is at the heart of what we do.
Through vertical integration, Tiger and its wholly owned subsidiaries offer all relevant aspects of modern tissue engineering. From idea conception, pre-clinical and clinical research, to processing and compliant distribution. Tiger covers the entire cascade of successful product management.